The severity of COVID-19 infection in children with leukemia

Ayça Koca Yozgat; Melek Isik; Dilek Kaçar; Zeliha Guzelkucuk; Burçin Kurtipek; Aslı Turgutoğlu Yılmaz; Volkan Köse; Dilek Gürlek; Turan Bayhan; Özlem Arman Bilir; İkbal Ok Bozkaya; Namık Yaşar Özbek; Hüsniye Neşe Yaralı

Makale detayları

The severity of COVID-19 infection in children with leukemia

Yazarlar:

Ayça Koca Yozgat | Melek Isik | Dilek Kaçar | Zeliha Guzelkucuk | Burçin Kurtipek | Aslı Turgutoğlu Yılmaz | Volkan Köse | Dilek Gürlek | Turan Bayhan | Özlem Arman Bilir | İkbal Ok Bozkaya | Namık Yaşar Özbek | Hüsniye Neşe Yaralı

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 4, pp.258-262

Belge Tipi:

Makale

Yayın Tarihi:

8/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001297605

pISSN:

2717-7505

Anahtar kelimeler:

Özet:

 Aims: The coronavirus disease 2019 COVID-19 has been the cause of a global health crisis since the end of 2019. The aim of this study was to evaluate the clinical findings and treatment results of COVID-19 disease in pediatric patients with leukemia. Methods: All the children and adolescents with severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive real-time polymerase chain reaction PCR and the presence of underlying leukemia were included in the study. Results: A total of 44 leukemia patients with COVID-19 infection were included in the study. Their primary diseases were as follows: 36 patients were newly diagnosed with acute lymphoblastic leukemia ALL, four patients were relapsed ALL, two patients were refractory ALL, and two patients were acute myeloblastic leukemia. The mean age of patients was 104 62 months. COVID-19 was asymptomatic in 11.4 of patients, mild in 84, and moderate in 4.5 whereas none of our patients had a severe infection. No severe complications andor death were observed in our study group. Conclusion: It has been found that the clinical course of COVID-19 is mild in children and adolescents with leukemia and undergoing chemotherapy or immunosuppressive therapy.

 Aims: The coronavirus disease 2019 COVID-19 has been the cause of a global health crisis since the end of 2019. The aim of this study was to evaluate the clinical findings and treatment results of COVID-19 disease in pediatric patients with leukemia. Methods: All the children and adolescents with severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive real-time polymerase chain reaction PCR and the presence of underlying leukemia were included in the study. Results: A total of 44 leukemia patients with COVID-19 infection were included in the study. Their primary diseases were as follows: 36 patients were newly diagnosed with acute lymphoblastic leukemia ALL, four patients were relapsed ALL, two patients were refractory ALL, and two patients were acute myeloblastic leukemia. The mean age of patients was 104 62 months. COVID-19 was asymptomatic in 11.4 of patients, mild in 84, and moderate in 4.5 whereas none of our patients had a severe infection. No severe complications andor death were observed in our study group. Conclusion: It has been found that the clinical course of COVID-19 is mild in children and adolescents with leukemia and undergoing chemotherapy or immunosuppressive therapy.

 Aims: The coronavirus disease 2019 COVID-19 has been the cause of a global health crisis since the end of 2019. The aim of this study was to evaluate the clinical findings and treatment results of COVID-19 disease in pediatric patients with leukemia. Methods: All the children and adolescents with severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive real-time polymerase chain reaction PCR and the presence of underlying leukemia were included in the study. Results: A total of 44 leukemia patients with COVID-19 infection were included in the study. Their primary diseases were as follows: 36 patients were newly diagnosed with acute lymphoblastic leukemia ALL, four patients were relapsed ALL, two patients were refractory ALL, and two patients were acute myeloblastic leukemia. The mean age of patients was 104 62 months. COVID-19 was asymptomatic in 11.4 of patients, mild in 84, and moderate in 4.5 whereas none of our patients had a severe infection. No severe complications andor death were observed in our study group. Conclusion: It has been found that the clinical course of COVID-19 is mild in children and adolescents with leukemia and undergoing chemotherapy or immunosuppressive therapy.

 Giriş: Koronavirüs hastalığı 2019 COVID-19, 2019 yılı sonundan itibaren küresel bir sağlık krizine neden olmuştur. Bu çalışmanın amacı, lösemi nedeni ile takipli pediatrik hastalarda COVID-19 hastalığının klinik bulgularını ve tedavi sonuçlarını değerlendirmektir. . Gereç-Yöntem: Şiddetli akut solunum sendromu koronavirüs-2 SARS-CoV-2 polimeraz zincir reaksiyonu pozitif olan lösemi tanısı ile takipli tüm çocuk ve ergen hastalar çalışmaya dahil edildi. Bulgular: Çalışmaya COVID-19 enfeksiyonu olan toplam 44 lösemi hastası dahil edildi. Primer tanıları açısından değerlendirildiğinde; 36 hasta yeni tanı akut lenfoblastik lösemi ALL, 4 hasta relaps ALL, 2 hasta refrakter ALL ve 2 hasta akut myeloblastik lösemi idi. Hastaların yaş ortalaması 10462 aydı. COVID-19 hastaların 11,4ünde asemptomatik, 84ünde hafif ve 4,5inde orta şiddette seyrederken hiçbir hastamızda ciddi enfeksiyon görülmedi. Hiçbir hastamızda ciddi komplikasyon veya ölümde gözlenmemiştir. Sonuç: Çalışmamızda lösemi tanısı ile takipli ve kemoterapi veya immünsüpresif tedavi gören çocuk ve ergenlerde COVID-19un klinik seyrinin hafif seyrettiği gözlemledik.

Makale detayları

The severity of COVID-19 infection in children with leukemia

Yazarlar:

Ayça Koca Yozgat | Melek Isik | Dilek Kaçar | Zeliha Guzelkucuk | Burçin Kurtipek | Aslı Turgutoğlu Yılmaz | Volkan Köse | Dilek Gürlek | Turan Bayhan | Özlem Arman Bilir | İkbal Ok Bozkaya | Namık Yaşar Özbek | Hüsniye Neşe Yaralı

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 4, pp.258-262

Belge Tipi:

Makale

Yayın Tarihi:

8/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001297605

pISSN:

2717-7505

Children

COVID-19

LeukemiaÇocuk

COVID-19

Lösemi

Sayı

Makale detayları

The severity of COVID-19 infection in children with leukemia

Yazarlar: Ayça Koca Yozgat | Melek Isik | Dilek Kaçar | Zeliha Guzelkucuk | Burçin Kurtipek | Aslı Turgutoğlu Yılmaz | Volkan Köse | Dilek Gürlek | Turan Bayhan | Özlem Arman Bilir | İkbal Ok Bozkaya | Namık Yaşar Özbek | Hüsniye Neşe Yaralı

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Çocuk Hematolojisi ve Onkolojisi | Sağlık Kurumları Yönetimi

Dergi: Journal of Medicine and Palliative Care Vol.4 Issue 4, pp.258-262

Belge Tipi: Makale

Yayın Tarihi: 8/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001297605

pISSN: 2717-7505

Children

COVID-19

LeukemiaÇocuk

COVID-19

Lösemi

Sayı

Yazarlar:

Ayça Koca Yozgat | Melek Isik | Dilek Kaçar | Zeliha Guzelkucuk | Burçin Kurtipek | Aslı Turgutoğlu Yılmaz | Volkan Köse | Dilek Gürlek | Turan Bayhan | Özlem Arman Bilir | İkbal Ok Bozkaya | Namık Yaşar Özbek | Hüsniye Neşe Yaralı

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 4, pp.258-262

Belge Tipi:

Makale

Yayın Tarihi:

8/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001297605

pISSN:

2717-7505